Skip to main content

Orgenesis Inc.

ORGSDelisted May 8, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001460602

Orgenesis Inc. was delisted on May 8, 2025; its insiders filed their last Form 4 on Dec 16, 2024; 1 institution reported holding it in 13F filings for Q1 2025, worth $124.0K in total; no superinvestor held it.

Holders of 5% or more of ORGS

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Orgenesis Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of ORGS
HolderLatest formStakeChangeFirst filedLatest filingFiling
Neurocords LLC13G18.84%1.20M sharesNewMar 14, 20251 filingMar 14, 2025SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

1 Schedule 13D or 13G filing on Orgenesis Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on ORGS
Filed (ET)FilerFormStakeChangeEvent dateFiling
Mar 14, 20254:05 PM ETNeurocords LLCand 1 other13G18.84%1.20M sharesNewMar 5, 2025SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Orgenesis Inc. shares.

No Form 144 notices for Orgenesis Inc. are on file.